Zheng Y - Search Results

1

Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models.

Bruno R, Bottino D, de Alwis DP, Fojo AT, Guedj J, Liu C, Swanson KR, Zheng J, Zheng Y, Jin JY. Bruno R, et al. Among authors: zheng j, zheng y. Clin Cancer Res. 2020 Apr 15;26(8):1787-1795. doi: 10.1158/1078-0432.CCR-19-0287. Epub 2019 Dec 23. Clin Cancer Res. 2020. PMID: 31871299 Free PMC article. Review.

2

Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthma.

Zhu R, Zheng Y, Dirks NL, Vadhavkar S, Jin JY, Peng K, Holweg CTJ, Olsson J, Matthews JG, Putnam WS. Zhu R, et al. Among authors: zheng y. Pulm Pharmacol Ther. 2017 Oct;46:88-98. doi: 10.1016/j.pupt.2017.08.010. Epub 2017 Aug 24. Pulm Pharmacol Ther. 2017. PMID: 28843617 Free article.

3

Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial Carcinoma.

Zheng Y, Narwal R, Jin C, Baverel PG, Jin X, Gupta A, Ben Y, Wang B, Mukhopadhyay P, Higgs BW, Roskos L. Zheng Y, et al. Clin Pharmacol Ther. 2018 Apr;103(4):643-652. doi: 10.1002/cpt.986. Epub 2018 Jan 17. Clin Pharmacol Ther. 2018. PMID: 29243222 Free PMC article.

4

PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria.

Oh E, Wada R, Le K, Zheng Y, Jin J, Poon V, Wong K, Owen R, Yoshida K. Oh E, et al. Among authors: zheng y. CPT Pharmacometrics Syst Pharmacol. 2023 Jun;12(6):795-807. doi: 10.1002/psp4.12953. Epub 2023 Mar 10. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36896910 Free PMC article.

5

Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status.

Baverel PG, Dubois VFS, Jin CY, Zheng Y, Song X, Jin X, Mukhopadhyay P, Gupta A, Dennis PA, Ben Y, Vicini P, Roskos L, Narwal R. Baverel PG, et al. Among authors: zheng y. Clin Pharmacol Ther. 2018 Apr;103(4):631-642. doi: 10.1002/cpt.982. Epub 2018 Feb 2. Clin Pharmacol Ther. 2018. PMID: 29243223 Free PMC article.

6

Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle.

Bartelink IH, Jones EF, Shahidi-Latham SK, Lee PRE, Zheng Y, Vicini P, van 't Veer L, Wolf D, Iagaru A, Kroetz DL, Prideaux B, Cilliers C, Thurber GM, Wimana Z, Gebhart G. Bartelink IH, et al. Among authors: zheng y. Clin Pharmacol Ther. 2019 Jul;106(1):148-163. doi: 10.1002/cpt.1211. Epub 2018 Oct 6. Clin Pharmacol Ther. 2019. PMID: 30107040 Free PMC article. Review.

7

Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid Tumors.

Glisson BS, Leidner RS, Ferris RL, Powderly J, Rizvi NA, Keam B, Schneider R, Goel S, Ohr JP, Burton J, Zheng Y, Eck S, Gribbin M, Streicher K, Townsley DM, Patel SP. Glisson BS, et al. Among authors: zheng y. Clin Cancer Res. 2020 Oct 15;26(20):5358-5367. doi: 10.1158/1078-0432.CCR-19-3070. Epub 2020 Aug 14. Clin Cancer Res. 2020. PMID: 32816951 Clinical Trial.

8

Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy.

Zhu R, Zheng Y, Putnam WS, Visich J, Eisner MD, Matthews JG, Rosen KE, D'Argenio DZ. Zhu R, et al. Among authors: zheng y. AAPS J. 2013 Apr;15(2):559-70. doi: 10.1208/s12248-013-9463-9. Epub 2013 Feb 15. AAPS J. 2013. PMID: 23413101 Free PMC article. Clinical Trial.

9

The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge.

Scheerens H, Arron JR, Zheng Y, Putnam WS, Erickson RW, Choy DF, Harris JM, Lee J, Jarjour NN, Matthews JG. Scheerens H, et al. Among authors: zheng y. Clin Exp Allergy. 2014 Jan;44(1):38-46. doi: 10.1111/cea.12220. Clin Exp Allergy. 2014. PMID: 24131304 Free PMC article. Clinical Trial.

10

Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients.

Sridhar S, Paz-Ares L, Liu H, Shen K, Morehouse C, Rizvi N, Segal NH, Jin X, Zheng Y, Narwal R, Gupta A, Dennis PA, Ye J, Mukhopadhyay P, Higgs BW, Ranade K. Sridhar S, et al. Among authors: zheng y. Clin Lung Cancer. 2019 Nov;20(6):e601-e608. doi: 10.1016/j.cllc.2019.06.020. Epub 2019 Jun 26. Clin Lung Cancer. 2019. PMID: 31327642 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34,185 results

Search Page